Harold Shlevin, CEO of Solvay Pharmaceuticals, Inc., Named to PhRMA Board of Directors
Marietta, Ga. (April 23, 2003) - Solvay Pharmaceuticals, Inc. announces that Harold Shlevin, Ph.D., president and chief executive officer, has been named to the board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA). Shlevin will serve a three year term from April 2003 to April 2006.
As a consortium of the country's leading research-based pharmaceutical and biotechnology companies, PhRMA is dedicated to promoting conditions that enable the discovery and development of new medications that will allow patients to live longer and enjoy healthier lives. PhRMA companies not only invest in future medical developments but also ensure availability of safe medicines to every sector of the American population today.
"Joining the leadership ranks of our industry's trade association is an honor for me personally and for Solvay Pharmaceuticals," said Shlevin. "As a company, Solvay Pharmaceuticals strives to fulfill specific, unmet medical needs, and our corporate mission coincides well with PhRMA's aims to protect, improve and enhance human health through medical innovation."
As president and chief executive officer of Solvay Pharmaceuticals, Shlevin focuses on strategically expanding the company's presence in the United States through aggressive acquisitions and research and development. Shlevin joined Solvay Pharmaceuticals as senior vice president of business development and scientific affairs in 1998 and became president and chief executive officer on June 1, 2000. He has three decades of diverse healthcare business-related experience, involving every aspect of the pharmaceutical industry from research and development to commercial operations. His past industry experience includes leadership roles at G.D. Searle and Co., Ciba-Geigy and Ciba Vision.
After earning a bachelor's degree from Boston University, Shlevin earned a master's and doctorate from Rochester Medical School. He holds post-doctoral degrees in pharmacology and physiology from the Mayo Graduate School of Medicine. Shlevin serves on the board of directors of the National Pharmaceutical Council and of the American Foundation for Suicide Prevention, and the board of advisors of Atlanta's Morehouse School of Medicine.
Solvay Pharmaceuticals, Inc. of Marietta, Georgia, is a research-based pharmaceuticals company, active in the therapeutic areas of cardiology, gastroenterology, mental health and women's health. It is a member of the worldwide Solvay S.A. chemical and pharmaceutical group, headquartered in Brussels, Belgium.
Contact: Catharine Sanders
Solvay Pharmaceuticals, Inc.
(770) 578-2160
